Skip to main content

Advertisement

SpringerLink
Log in

Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Plasma ceruloplasmin (Cp) has been shown to be a risk factor for cardiovascular disease and also to be associated with obesity. However, it is not known whether weight loss could decrease the plasma Cp levels. Aim: To investigate the effect of diet-induced weight loss on plasma Cp in obese women. Subjects and methods: Sixty-seven healthy obese women [age =33.4±8.7 yr, body mass index (BMI) =36.0±4.8 kg/m2] were entered into a medically supervised program aimed at reducing body weight by 10% or more. Weight loss was achieved through a diet providing a daily energy deficit of 500–1000 kcal/day. In addition, all patients were prescribed to use 50 g of a fiber supplement per day. For all subjects, assessment of dietary intake, anthropometric indices, and plasma levels of C-reactive protein and Cp was performed at the first visit and repeated at 12thweek of follow-up. Results: By completing the program, weight (Δ=-9.5%, p<0.0001), BMI (Δ=−9.7%, p<0.0001), waist-circumference (Δ=−6.1 %, p<0.0001), and triceps skin-fold thickness (Δ=−14.9%, p<0.0001) significantly decreased. Plasma Cp significantly decreased after 12 weeks of dietary intervention (33.6±5.6 mg/dl vs 25.2±5.8 mg/dl, p<0.0001). Percent change in Cp was correlated with percent change in waist-circumference (r=446, p=0.015). Conclusion: Our study suggests that an improved body composition induced by restriction of energy intake is associated with decreased serum concentrations of Cp in obese women which in turn might have reduced the subjects’ risk of developing cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 2007, 356: 213–5.

    Article  PubMed  Google Scholar 

  2. Mello MM, Studdert DM, Brennan TA. Obesity—the new frontier of public health law. N Engl J Med 2006, 354: 2601–10.

    Article  PubMed  Google Scholar 

  3. Sonnett TE, Levien TL, Gates BJ, Robinson JD, Campbell RK. Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies. Ann Pharmacother 2010, 44: 701–11.

    Article  PubMed  Google Scholar 

  4. Li H, Xie Z, Lin J, et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J Proteome Res 2008, 7: 4775–83.

    Article  PubMed  Google Scholar 

  5. Bouchard L, Rabasa-Lhoret R, Faraj M, et al. Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr 2010, 91: 309–20.

    Article  PubMed  Google Scholar 

  6. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52: 2097–101.

    Article  PubMed  Google Scholar 

  7. Engstrom G, Hedblad B, Stavenow L, et al. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study. Arterioscler Thromb Vasc Biol 2004, 24: 1498–502.

    Article  PubMed  Google Scholar 

  8. Lind P, Hedblad B, Stavenow L, Janzon L, Eriksson KF, Lindgarde F. Influence of plasma fibrinogen levels on the incidence of myocardial infarction and death is modified by other inflammation-sensitive proteins: a long-term cohort study. Arterioscler Thromb Vasc Biol 2001, 21: 452–8.

    Article  PubMed  Google Scholar 

  9. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002, 105: 2632–7.

    Article  PubMed  Google Scholar 

  10. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003, 107: 391–7.

    Article  PubMed  Google Scholar 

  11. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340: 115–26.

    Article  PubMed  Google Scholar 

  12. Macintyre G, Gutfreund KS, Martin WR, Camicioli R, Cox DW. Value of an enzymatic assay for the determination of serum ceruloplasmin. J Lab Clin Med 2004, 144: 294–301.

    Article  PubMed  Google Scholar 

  13. Giurgea N, Constantinescu MI, Stanciu R, Suciu S, Muresan A. Ceruloplasmin — acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med Sci Monit 2005, 11: RA48–51.

    PubMed  Google Scholar 

  14. McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 1993, 14: 1493–8.

    Article  PubMed  Google Scholar 

  15. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med 2000, 28: 1735–44.

    Article  PubMed  Google Scholar 

  16. Göçmen AY, Sahin E, Semiz E, Gümuslü S. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease? Can J Cardiol 2008, 24: 209–12.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kim OY, Shin MJ, Moon J, Chung JH. Plasma ceruloplasmin as a biomarker for obesity: A proteomic approach. Clin Biochem 2011, 44: 351–6.

    Article  PubMed  Google Scholar 

  18. Cignarelli M, Depergola G, Picca G, et al. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obes Relat Metab Disord 1996, 20: 809–13.

    PubMed  Google Scholar 

  19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–9.

    Article  PubMed  Google Scholar 

  20. Rao SV, Donahue M, Pi-Sunyer FX, Fuster V. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease. Am Heart J 2001, 142: 1102–7.

    Article  PubMed  Google Scholar 

  21. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999, 22: 1971–7.

    Article  PubMed  Google Scholar 

  22. Festa A, D’Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001, 25: 1407–15.

    Article  PubMed  Google Scholar 

  23. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115: 911–9.

    Article  PubMed  Google Scholar 

  24. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003, 27(Suppl 3): S25–8.

    Article  PubMed  Google Scholar 

  25. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999, 19: 972–8.

    Article  PubMed  Google Scholar 

  26. Böyük A, Banlı O, Gümüs M, Evliyaoglu O, Demirelli S. Plasma Levels of Zinc, Copper, and Ceruloplasmin in Patients after Undergoing Laparoscopic Adjustable Gastric Banding. Biol Trace Elem Res 2011, 143: 1282–8.

    Article  PubMed  Google Scholar 

  27. Reunanen A, Knekt P, Aaran RK. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992, 136: 1082–90.

    PubMed  Google Scholar 

  28. Ferns GA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 1997, 133: 139–52.

    Article  PubMed  Google Scholar 

  29. Bustamante JB, Mateo MC, Fernandez J, de Quiros B, Manchado OO. Zinc, copper and ceruloplasmin in arteriosclerosis. Biomedicine 1976, 25: 244–5.

    PubMed  Google Scholar 

  30. Powell JT, Muller BR, Greenhalgh RM. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 1987, 28: 528–30.

    Google Scholar 

  31. Alissa EM, Bahjri SM, Al-Ama N, Ahmed WH, Ferns GA. High cardiovascular risk in young Saudi males: cardiovascular risk factors, diet and inflammatory markers. Clin Chim Acta 2006, 365: 288–96.

    Article  PubMed  Google Scholar 

  32. Ford ES. Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol 2000, 151: 1182–8.

    Article  PubMed  Google Scholar 

  33. Jeremy JY, Shukla N, Muzaffar S, Handley A, Angelini GD. Reactive oxygen species, vascular disease and cardiovascular surgery. Curr Vasc Pharmacol 2004, 2: 229–36.

    Article  PubMed  Google Scholar 

  34. Ehrenwald E, Chisolm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994, 93: 1493–501.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Makedou KG, Mikhailidis DP, Makedou A, et al. Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia. Angiology 2009, 60: 455–61.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nutrition and Biochemistry Department, School of public Health, Tehran, Iran

    N. Tajik, A. Golpaie, S. A. Keshavarz, M. Djalali, Z. Ahmadivand, F. Fatehi & M. Zare

  2. Endocrine and Metabolism Research Center (EMRC), Obesity and Food Group Set, Tehran, Iran

    N. Tajik, A. Golpaie & T. Yazdani

  3. Epidemiology and Biostatistics Department, School of Public Health, Tehran, Iran

    M. Sehat

  4. Students’ Scientific Research Center (SSRC), Faculty of Medicine, Tehran University of Medical Sciences, Poursina Ave., Qods St., P.O.Box: 14155, Tehran, Iran

    F. Masoudkabir MD, MPH

Authors
  1. N. Tajik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Golpaie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. A. Keshavarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Djalali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Sehat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Masoudkabir MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z. Ahmadivand
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. F. Fatehi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Zare
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. T. Yazdani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Masoudkabir MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tajik, N., Golpaie, A., Keshavarz, S.A. et al. Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women. J Endocrinol Invest 35, 566–569 (2012). https://doi.org/10.3275/7878

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/7878

Key-words

Search

Navigation